Oslo - Delayed Quote NOK

Lytix Biopharma AS (LYTIX.OL)

7.60
-0.10
(-1.30%)
At close: May 16 at 4:25:26 PM GMT+2
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-70,372
-70,372
-95,969
-52,626
-44,607
Investing Cash Flow
24,693
24,693
29,725
-49,355
138
Financing Cash Flow
149,105
149,105
-943
-749
213,302
End Cash Position
130,791
130,791
27,365
94,552
197,282
Capital Expenditure
--
--
-49
-154
--
Issuance of Capital Stock
161,295
161,295
0
133
225,214
Repayment of Debt
--
--
-940
-827
-423
Free Cash Flow
-70,372
-70,372
-96,018
-52,780
-44,607
12/31/2021 - 6/14/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers